Nordic Gastric and Esophageal Tumor Study

CompletedOBSERVATIONAL
Enrollment

900,000

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 28, 2022

Study Completion Date

December 28, 2022

Conditions
Cancer of StomachCancer of the EsophagusDrug Use
Interventions
DRUG

Proton pump inhibitor

Long-term use of medications, particularly proton pump inhibitors

Trial Locations (1)

171 77

Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

collaborator

University of Oulu

OTHER

collaborator

Norwegian University of Science and Technology

OTHER

collaborator

Reykjavik University

OTHER

lead

Karolinska Institutet

OTHER

NCT05688761 - Nordic Gastric and Esophageal Tumor Study | Biotech Hunter | Biotech Hunter